ICI Therapy Toxicities In Psoriasis

    Haig Pakhchanian, Rahul Raiker, Erisa Alia, Mairead R. Baker, Min Deng
    Studysummary This study found that patients receiving immune checkpoint inhibitors who have a history of psoriasis are at a higher risk for developing gastrointestinal and endocrine toxicities within one year compared to those without psoriasis.
    Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
    Discuss this study in the Community →